4//SEC Filing
Brown Ryan Edward 4
Accession 0000950170-24-077522
CIK 0000873303other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 8:00 PM ET
Size
29.8 KB
Accession
0000950170-24-077522
Insider Transaction Report
Form 4
Brown Ryan Edward
SVP, General Counsel
Transactions
- Sale
Common Stock
2024-06-25$162.65/sh−17,581$2,859,550→ 23,518 total - Award
Performance Stock Units
2024-06-21+5,500→ 5,500 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2024-06-21+6,250→ 34,938 total - Exercise/Conversion
Common Stock
2024-06-25$62.77/sh+23,500$1,475,095→ 56,086 total - Sale
Common Stock
2024-06-25$158.07/sh−7,644$1,208,287→ 48,442 total - Sale
Common Stock
2024-06-25$161.82/sh−4,168$674,466→ 41,099 total - Sale
Common Stock
2024-06-25$164.52/sh−2,549$419,361→ 17,129 total - Tax Payment
Common Stock
2024-06-24$164.64/sh−2,352$387,233→ 32,586 total - Sale
Common Stock
2024-06-25$159.14/sh−2,200$350,108→ 46,242 total - Sale
Common Stock
2024-06-25$163.53/sh−3,840$627,955→ 19,678 total - Exercise/Conversion
Performance Stock Units
2024-06-21−6,250→ 0 total→ Common Stock (6,250 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-06-25−23,500→ 0 totalExercise: $62.77From: 2019-02-28Exp: 2028-02-28→ Common Stock (23,500 underlying) - Sale
Common Stock
2024-06-25$160.31/sh−975$156,302→ 45,267 total - Award
Performance Stock Units
2024-06-21+6,250→ 6,250 total→ Common Stock (6,250 underlying)
Footnotes (10)
- [F1]Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU.
- [F10]Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date.
- [F2]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.58 to $158.52, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.67 to $159.66, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.71 to $160.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.04 to $162.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.12 to $163.09, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.19 to $163.98 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001848718
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 8:00 PM ET
- Size
- 29.8 KB